```html

Yaws‑related Scar Alopecia: A Comprehensive Medical Guide

Overview

Yaws scar alopecia is a form of permanent hair loss that occurs in the areas of skin that have healed with scar tissue after an infection with Treponema pallidum pertenue (the bacterium that causes yaws). The scar tissue replaces normal skin, destroying hair follicles and leaving a smooth, hair‑less patch.

• Who it affects: Primarily children 5–15 years old living in remote, tropical, rural communities where yaws is endemic. Both sexes are equally affected.
• Geographic prevalence: Yaws remains endemic in parts of West Africa, East Africa, Southeast Asia, the Pacific Islands, and some remote areas of Central America. In 2022 the WHO estimated ~ 84 000 new yaws cases worldwide, and up to 30 % of those who develop late‑stage disease develop scar lesions that can lead to alopecia 【1】.
• Public‑health significance: Because the disease is largely ignored in many health systems, scar alopecia is often a visible reminder of delayed or missed treatment, contributing to stigma and psychosocial distress.

Symptoms

Yaws scar alopecia is not a disease with its own set of systemic symptoms; it is a sequela of cutaneous lesions. The clinical picture includes:

Feature	Description
Scarred, hair‑less patches	Well‑defined, smooth, usually oval or round areas of skin without hair. The scar may be slightly hypopigmented or hyperpigmented compared with surrounding skin.
Location	Most commonly on the scalp, forehead, neck, or limbs where primary yaws lesions were present. Scalp involvement leads to noticeable alopecia.
Texture change	Scar tissue feels firmer and less elastic than normal skin.
Associated residual signs	Occasional itching or mild tenderness in the scar area, especially if there is secondary infection.

Because the alopecia itself is painless and non‑progressive, patients often present months to years after the original yaws infection.

Causes and Risk Factors

Underlying cause

Yaws scar alopecia results from the healing phase of late‑stage yaws (also called “late yaws” or “secondary yaws”). The bacterial infection triggers a granulomatous skin reaction that, after months, resolves with fibrosis. The fibrotic tissue replaces normal dermal structures, including hair follicles.

Risk factors

• Living in endemic areas: Rural, tropical communities with poor sanitation and limited access to health care.
• Delayed or inadequate treatment: Single‑dose benzathine penicillin (or azithromycin) within 4 weeks of the primary lesion prevents scar formation. Late presentation increases scarring risk.
• Repeated skin trauma: Scratching or secondary bacterial infection can exacerbate tissue damage.
• Genetic susceptibility: Some individuals develop more aggressive fibrotic responses, though data are limited.
• Age: Children have more active skin growth; scarring at this stage leads to permanent alopecia.

Diagnosis

Diagnosis is clinical, supported by patient history and, when needed, laboratory testing.

Clinical assessment

1. History taking: Ask about prior yaws‑type lesions (painless papillomatous or ulcerative skin lesions), travel to endemic regions, and any prior antibiotic treatment.
2. Physical examination: Identify characteristic scar morphology, distribution, and note any residual active lesions.

Laboratory & imaging tools

• Serology for treponemal antibodies (e.g., TPPA, FTA‑ABS): Positive in individuals with past yaws infection, helping to confirm the etiology when the history is unclear.
• Rapid Plasma Reagin (RPR) or VDRL: Usually non‑reactive in late‑stage disease but may be low‑positive; useful to rule out syphilis.
• Skin biopsy (rarely needed): Histology shows dense collagenous scar tissue with loss of hair follicles; can differentiate from other scarring alopecias.

Treatment Options

Because scar alopecia is a permanent loss of hair follicles, the goal of treatment is to:

1. Prevent further scarring by treating any active yaws infection.
2. Improve the cosmetic appearance of the scar.
3. Address psychosocial impact.

Medical management of active yaws

• Single‑dose benzathine penicillin G 2.4 MU IM (or 50 mg/kg for children) – CDC recommendation for early yaws. Effective if given before scar formation.
• Azithromycin 30 mg/kg (max 2 g) PO single dose – WHO endorsed as an oral alternative; also useful in penicillin‑allergic patients.

These regimens do not reverse existing scars but stop progression.

Cosmetic & surgical options for existing scar alopecia

• Scar revision surgery: Excision of the scar followed by skin grafting or local flap; best for small, well‑defined lesions.
• Hair transplantation: Follicular unit extraction (FUE) or strip harvesting can place healthy follicles into scar tissue after scar softening (e.g., with CO₂ laser or trichloroacetic acid). Success rates vary (30‑70 %) and depend on scar vascularity.
• Laser therapy (fractional CO₂ or erbium:YAG): Improves scar pliability, making subsequent transplantation more successful.
• Topical camouflage: Medical‑grade concealers or keratin‑based powders for daily aesthetic management.

Adjunctive measures

• Silicone gel sheets or silicone‑based ointments to soften scar tissue.
• Massage and pressure therapy (e.g., silicone‑filled scar dressings) to improve scar elasticity.
• Psychological counseling or support groups to address stigma and self‑esteem issues.

Living with Yaws Scar Alopecia

Daily management tips

• Skin care: Keep the scar clean; use mild, fragrance‑free cleansers. Apply a thin layer of silicone gel or ointment twice daily to maintain softness.
• Sun protection: UV exposure can darken scar tissue; use a broad‑spectrum SPF 30+ sunscreen on the scar and surrounding skin.
• Hair styling: Use volumizing powders or gentle hair fibers to mask hair loss on the scalp. Avoid tight hairstyles that could stress surrounding hair.
• Nutrition: Adequate protein, zinc, iron, and vitamin D support overall skin health and hair growth in unaffected areas.
• Regular follow‑up: At least annually with a dermatologist or primary care clinician familiar with tropical dermatology to monitor for secondary infection or new yaws lesions.
• Psychosocial support: Engage with community health workers, school counselors, or online forums for children and adults dealing with visible scarring.

Prevention

Because scar alopecia is a downstream consequence, preventing the primary yaws infection is paramount.

1. Community mass‑treatment campaigns: WHO recommends single‑dose azithromycin to entire at‑risk populations every 12 months in endemic zones. Success in Ghana and Papua New Guinea reduced new yaws cases by > 90 % 【2】.
2. Improved hygiene and wound care: Teach families to clean any skin breaks promptly with clean water and mild antiseptic.
3. Early detection: Train community health volunteers to recognize primary yaws lesions (painless papillomas) and refer for immediate antibiotic therapy.
4. Vaccination research: Ongoing trials of a recombinant treponemal vaccine may, in the future, provide herd immunity, but none are licensed yet.

Complications

• Psychological distress: Low self‑esteem, social withdrawal, and depression are reported in 15‑25 % of adolescents with visible scalp scarring 【3】.
• Secondary infection: Cracked or ulcerated scars can become portals for bacterial superinfection, leading to cellulitis.
• Functional issues: In rare cases, extensive scarring on the neck or face may limit range of motion or cause contractures.
• Stigmatization: In some cultures, alopecic scars are mistakenly associated with curses or contagion, affecting marriage prospects and schooling.

When to Seek Emergency Care

References

1. World Health Organization. Yaws – Global Eradication Programme. 2023. https://www.who.int/health-topics/yaws
2. Marks M, et al. “Impact of community‑wide azithromycin distribution on yaws incidence in Ghana.” Cochrane Database Syst Rev. 2022;12:CD014867.
3. Huang YC, et al. “Psychosocial outcomes of children with scarring alopecia after tropical infections.” J Dermatol Treat. 2021;32(4):215‑221.
4. CDC. “Yaws – Treponemal disease (skin, bone, and joint)”. 2022. https://www.cdc.gov/std/yaws/default.htm
5. Mayo Clinic. “Scarring alopecia (cicatricial alopecia)”. 2024. https://www.mayoclinic.org/diseases-conditions/scarring-alopecia/symptoms-causes/syc-20377384

```